Description:Rabbit polyclonal antibody to Vimentin (Phospho-S56)Immunogen:KLH-conjugated synthetic phosphopeptide corresponding to residues surrounding S56 of human Vimentin protein. The exact sequence is proprietary.Purification:The antibody was purified by immunogen affinity chromatography.Clonality:PolyclonalForm:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100)Gene Symbol:VIMAlternative Names:Vimentin
Entrez Gene (Human):
7431;
Entrez Gene (Mouse):
22352;
Entrez Gene (Rat):
81818;
SwissProt (Human):
P08670;
SwissProt (Mouse):
P20152;
SwissProt (Rat):
P31000;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of Vimentin (Phospho-S56) expression in H1688 (A) whole cell lysates. (Predicted band size: 53 kD; Observed band size: 57 kD)
-
Immunohistochemical analysis of Vimentin (Phospho-S56) staining in human breast cancer formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation